ResearchDx specializes in biomarker discovery, assay design, and assay development through an unparalleled complement of services that includes non-clinical / pre-clinical sample access and processing capabilities, comprehensive genetic and genomic testing platforms, and bioinformatics expertise, as well as both Next Generation (NGS) and Sanger sequencing.
Next Generation Sequencing Applications/Services we offer:
- Whole Genome Sequencing
- Exome Sequencing
- Disease panel and Pathway Gene analysis
- DNA Methylation Sequencing
- Microbiome 16S rRNA
- Small RNA
- Total RNA/mRNA Whole Transcriptome (RNAseq)
- Total RNA/mRNA 3’Differential Gene Expression (tag profilingshRNA)
We have the ability to provide these sequencing services as Research, CLIA/CAP or GXP compliant. Please contact us about your needs!
Why utilize ResearchDx for your NGS service needs?
The team at ResearchDx have unparalleled expertise in Next Generation Sequencing. We are one of few companies that have successfully assisted clients with multiple NGS 510 (k) and PMA FDA regulatory submission and approvals, while also maintaining a leadership position in providing services to leading NGS clinical laboratory service providers.
At ResearchDx, we offer several optimized NGS processes and we consistently provide high quality data, customized annotation and reporting, and fast turnaround times. We offer an array of NGS solutions and platforms, backed by a team of experts to guide you through the best practices for this fast evolving technology.